Anticoagulants, renal failure and atrial fibrillation

By Genovesi Simonetta  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

By  

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban

By Messori Andrea   Maratea Dario   Fadda Valeria   Trippoli Sabrina  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 505-506

Springer Publishing Company

Access to resources Recommend Favorite

New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation: Assessing the Impact on Medication Adherence

By Kopecky Stephen  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim   Schott Gisela  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite